healthcare transparency

Launched in 1992, the 340B program requires drug manufacturers that participate in Medicaid to provide outpatient medications at substantial discounts to providers that serve large numbers of uninsured, underinsured and Medicaid patients. #drugpricing #lawmakers #capitolnewsillinois

Even with major progress on insulin affordability, many people with diabetes struggle under the weight of a costly system.

Op-Ed: Health Equity Requires More Than Good Intentions: Why 340B Needs Transparency Before Expansion - Black women and families in underserved communities face some...

Critics point to financial data suggesting 340B-participating hospitals in Illinois report significantly higher average patient revenues than non-participating hospitals. #drug #proposals #critics

Affordability is certainly an important factor for patients but so is accessibility. #prescription